Piper Jaffray resumes coverage on DepoMed Inc (NASDAQ: DEPO) with a Overweight rating and a price target of $23.00.Analyst David ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE